Japanese, multi-center, observational study for hospitalized patients with community-acquired, hospital-acquired, and ventilator-associated pneumonia
Not Applicable
Recruiting
- Conditions
- Community-acquired (CAP) including COVID-19, hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)
- Registration Number
- JPRN-UMIN000042522
- Lead Sponsor
- agoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who do not receive initial empirical antibiotic treatment 2) Patients with obstructive pneumonia 3) Pneumonia occurred in other hospitals and patients who were transferred from their hospitals with a trend toward improvement 4) Patients whose pneumonia recurred within 3 days after the last day of antibiotic treatment of a preceding pneumonia episode 5) Patients who receive the treatment in outpatient clinics 6) Patients who are less than 20 years old
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) 30-day mortality, 90-day mortality and in-hospital mortality 2) Identified pathogens and drug resistance 3) Early and late treatment failure 4) Severe adverse events 5) Readmission within 90 days after discharge 6) Appropriateness of antibiotic treatment
- Secondary Outcome Measures
Name Time Method